Efficacy of isatuximab/pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA-MM high-risk cytogenetics subgroup analysis

Autor:	Harrison, Simon J. 1, Richardson, Paul G. 2, Alegre, Adrian 3, Simpson, David 4, Wang, Ming Chung 5, Spencer, Andrew 6, Delimpasi, Sossana 7, Hulin, Cyrille 8, Sunami, Kazutaka 9, Facon, Thierry 10, Vlummens, Philip 11, Yong, Kwee 12, Campana, Frank 13, Inchauspé, Marlène 14, Macé, Sandrine 15, Risse, Marie-Laure 16, van de Velde, Helgi 17, Attal, Michel 18
Zdroj:	In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e33-e33
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect